Skip to content
HowShorted

OPKO Health, Inc. short interest in 2022

In 2022, OPKO Health, Inc.'s disclosed short interest ran from 6.43% of shares outstanding on 14 Jan 2022 to 4.97% on 30 Dec 2022, a change of -1.46 percentage points. The year's high was 7.96% on 15 Jun 2022 and its low 4.76% on 15 Dec 2022, averaging 6.04% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.55 days on 15 Jul 2022. Full history: OPKO Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for OPKO Health, Inc. in 2022

2022 in figures

Start of year
6.43% (14 Jan 2022)
End of year
4.97% (30 Dec 2022)
Change
-1.46 pp
High
7.96% (15 Jun 2022)
Low
4.76% (15 Dec 2022)
Average
6.04%
Highest days to cover
22.55 (15 Jul 2022)
SEC filings marked
8

Every report in 2022

OPKO Health, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20226.43%10.83
31 Jan 20226.33%5.00
15 Feb 20226.33%10.78
28 Feb 20226.80%10.74results (8-K)
15 Mar 20226.33%10.6010-K filed
31 Mar 20226.69%9.08
14 Apr 20226.59%15.03
29 Apr 20226.89%12.90
13 May 20227.02%8.5410-Q filed, results (8-K)
31 May 20227.21%12.89
15 Jun 20227.96%9.98
30 Jun 20227.01%6.48
15 Jul 20227.14%22.55
29 Jul 20226.43%20.78
15 Aug 20225.71%10.2110-Q filed, results (8-K)
31 Aug 20225.06%12.98
15 Sep 20224.94%16.92
30 Sep 20224.84%14.85
14 Oct 20224.85%21.13
31 Oct 20224.85%18.74
15 Nov 20224.83%16.5110-Q filed, results (8-K)
30 Nov 20224.93%12.54
15 Dec 20224.76%18.76
30 Dec 20224.97%13.06

See also: OPKO Health, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.